Biodistribution of progesterone in the eye after topical ocular administration via drops or inserts.
Biodistribution
Drops
Insert
Methyl-β-cyclodextrin
Ocular
Progesterone
UPLC-MS/MS
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
05 Jan 2023
05 Jan 2023
Historique:
received:
03
10
2022
revised:
21
11
2022
accepted:
24
11
2022
pubmed:
2
12
2022
medline:
21
12
2022
entrez:
1
12
2022
Statut:
ppublish
Résumé
Progesterone (PG) has been shown to have a slowing effect on photoreceptor cell death in mouse models of retinitis pigmentosa when administered orally. The aim of this study was to investigate whether ophthalmically administered progesterone was able to reach neuroretina and thus, the distribution through ocular tissues of different PG formulations was studied. The effect of different initial PG concentration was also investigated. Different formulations with PG in their composition (drops, a corneal/scleral-insert and scleral-inserts) were prepared and assayed. Using whole porcine eyes, the different formulations were topically administered to the ocular surface. Frozen eyes were dissected, the PG in each tissue was extracted in acetonitrile and the amount of PG quantified by UHPLC-MS/MS. Our results show that after topical administration, PG diffuses from the ocular surface and distributes throughout all tissues of the eye. Lower levels of PG were found in sclera, choroid and neuroretina when PG was applied as drops compared to inserts. Our results also show that an increase in the initial PG concentrations applied, resulted in a statistically significant increase in the amounts of PG in aqueous humour, sclera, choroid and neuroretina.
Identifiants
pubmed: 36455753
pii: S0378-5173(22)01008-0
doi: 10.1016/j.ijpharm.2022.122453
pii:
doi:
Substances chimiques
Progesterone
4G7DS2Q64Y
Ophthalmic Solutions
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122453Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.